Thromboembolism: all 818 studies
Page 4 of 9. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims DataCompletedNCT05264168
- Is Anti-Factor Xa Associated With Outcome in Patients With Critical COVID-19 on Low-Molecular-Weight Heparin?CompletedNCT05256524
- The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal PatientsWithdrawnNCT05246943
- Anti-factor Xa Based Venous Thromboembolism ProphylaxisCompletedNCT05221879Not applicable
- Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)CompletedNCT05209048
- Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid SyndromeCompletedNCT05195372
- The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19CompletedNCT05195242Phase 3
- A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee ReplacementStatus unknownNCT05189002Phase 2
- Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19CompletedNCT05185804Phase 3
- The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic CancerStatus unknownNCT05178628Phase 3
- Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PETerminatedNCT05172115Phase 3
- Inflammatory Bowel Disease and Thromboembolic EventsCompletedNCT05162339
- A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)CompletedNCT05150938
- Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking EnoxaparinStatus unknownNCT05150314
- Stand-alone Left Atrial Appendage Occlusion for Thromboembolism PreventionStatus unknownNCT05144958
- Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic ComplicationsCompletedNCT05143567Not applicable
- A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)CompletedNCT05112666
- Sonoclot to Evaluate Thrombotic Risk in Proteinuric PregnancyStatus unknownNCT05108389
- SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD SurgeryWithdrawnNCT05104229Phase 3
- Prevalence and Risk Factors of Chronic Thrombo-embolic Disease After a Pulmonary Embolism EventCompletedNCT05073666
- Thromboprophylaxis in Oesophageal Cancer PatientsStatus unknownNCT05067153Phase 4
- LMWH Compliance in PregnancyStatus unknownNCT05066867
- Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study)CompletedNCT05058521
- THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)TerminatedNCT05033314Phase 3
- Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs EnoxaparinStatus unknownNCT04999176Phase 3
- Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States CohortCompletedNCT04979780
- the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory InpatientsCompletedNCT04963374
- Effect of the Genotype on Postoperative DVTCompletedNCT04940377
- A Study to Learn About Venous Thromboembolism (VTE) Treatment With Rivaroxaban in Japanese Patients Using a Claims DatabaseCompletedNCT04923139
- Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic EpisodeCompletedNCT04920487
- Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to ApixabanTerminatedNCT04895553
- Thromboprophylaxis by Low Molecular Heparin During the Post-partum PeriodCompletedNCT04883385
- Venous Thrombosis Virtual Surveillance in COVID-19CompletedNCT04865913
- Venous Phase Dual Energy CT in Patients Suspected for Pulmonary Embolism.Status unknownNCT04859478Not applicable
- Causes and Prevention of Thromboembolic Disease in Nephrotic SyndromeCompletedNCT04850378Phase 1/2
- Predictors of Attempted Inferior Vena Cava Filters Retrieval.CompletedNCT04846725
- Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIOCompletedNCT04846556
- Clotting Parameters After Medical AbortionCompletedNCT04824118
- Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS DataCompletedNCT04818151
- COVID-19 Pathophysiology of Long Term ImplicationsStatus unknownNCT04813575Not applicable
- A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill PatientsCompletedNCT04768036Not applicable
- Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual BleedingTerminatedNCT04748393
- Cellular-Mediated Immunity in COVID-19Status unknownNCT04746521
- Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical TreatmentCompletedNCT04744688
- Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims DataCompletedNCT04736719
- Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims DataCompletedNCT04735523
- A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male ParticipantsCompletedNCT04720092Phase 1
- Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19CompletedNCT04719182
- Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.TerminatedNCT04710732Phase 4
- Endovascular thromBectomy of Acute Mesentery Vessels Occlusion Hybrid With Emergent Laparoscopic SurgeryCompletedNCT04686981
- Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AFWithdrawnNCT04684212Not applicable
- Development and Validation of the Patient-completed Caprini Risk ScoreStatus unknownNCT04663477
- Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE TrialCompletedNCT04662684Phase 3
- WHITE Study: WHIch Decision After a First Venous ThromboEmbolism?CompletedNCT04646993
- Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 PatientsCompletedNCT04593654
- Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort StudyStatus unknownNCT04588805
- Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) EventsCompletedNCT04574895Not applicable
- COVID-19 and Venous Thromboembolism RiskCompletedNCT04569344
- Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19CompletedNCT04567927
- Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.TerminatedNCT04558892Phase 2/3
- COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic ComplicationsCompletedNCT04535128
- Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")CompletedNCT04510987Phase 1
- Influence of Cardiac Implantable Electronic Devices on the Hemostatic SystemCompletedNCT04499612
- Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer SurgeryCompletedNCT04479579Phase 4
- Safety of Fondaparinux as Post Partum ThromboprophylaxisCompletedNCT04447378Phase 4
- Venous Disease Thromboembolic and Amyotrophic Lateral SclerosisCompletedNCT04446325
- Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in GermanyCompletedNCT04444804
- A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 PandemicCompletedNCT04444700Phase 3
- Risk Stratification for Venous Thromboembolism in Hospitalized Medical PatientsCompletedNCT04439383
- Thrombosis Risk Assessment and Clinical Presentation of Covid-19 PneumoniaCompletedNCT04423315
- Registry of Angiovac Procedures In Detail Outcomes Database-RAPID RegistryCompletedNCT04414332
- Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 PatientsCompletedNCT04412304
- Thromboembolic Events in Severe COVID-19 PatientsStatus unknownNCT04405869
- Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 PandemicCompletedNCT04400877
- Impact of an Intensified Thromboprofylaxis Protocol in COVID-19CompletedNCT04394000
- Improving Safety of Diagnosis and Therapy in the Inpatient SettingCompletedNCT04393909Not applicable
- Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19CompletedNCT04374617
- Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19CompletedNCT04373707Phase 4
- Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute PneumopathyCompletedNCT04366752
- Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19CompletedNCT04359212
- Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)CompletedNCT04335162
- Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean DeliveryCompletedNCT04305756Not applicable
- Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer PatientsStatus unknownNCT04301362
- Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic EventsStatus unknownNCT04294589
- Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine PhysiciansCompletedNCT04272723
- Efficacy of the Use of Risk Scores in Reducing Important Clinical Outcomes in Hospitalized Medical Ill PatientsCompletedNCT04267718Not applicable
- Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical InpatientsCompletedNCT04257305
- Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for ThromboembolismStatus unknownNCT04246073
- Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm PatientsCompletedNCT04243122Phase 2
- Prognostic Tools in Patients With Acute Pulmonary Thromboembolism.Status unknownNCT04237974
- Perioperative Anticoagulant Use for Surgery Evaluation Emergency RegistryCompletedNCT04195113
- The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety StudyStatus unknownNCT04179487
- Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs RivaroxabanStatus unknownNCT04169269Phase 4
- CHIPs-VTE Study in Hospitalized Patients With Lung CancerStatus unknownNCT04158973Not applicable
- A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy VolunteersCompletedNCT04157881Phase 4
- Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityCompletedNCT04153760Early Phase 1
- Study on the Effect of a Physical Training Structured Program After a Pulmonary ThromboembolismStatus unknownNCT04150003Not applicable
- Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism.Status unknownNCT04141254Phase 3
- A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the USCompletedNCT04141228
- Thrombus Elastography in Venous Thrombo-Embolism.Status unknownNCT04130048